Bis(6-(8-fluoro-3,4-dihydro-1H-[1]benzofuro[3,2-c]pyridin-2-yl)-N,N-dimethyl-1,3-benzothiazol-2-amine);5-(8-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-N-propan-2-yl-1,3-benzothiazol-2-amine;4-[5-(8-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-2-pyridinyl]morpholine;4-[5-(12-fluoro-8-methyl-4,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),10,12-tetraen-4-yl)-1,3-benzothiazol-2-yl]morpholine;4-[5-(9-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-1,3-benzothiazol-2-yl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-3-pyridinyl]morpholine
C147H146F7N27O6S5 — CID 158767357
Data last refreshed: (MolForge compound catalog, from PubChem)
About Bis(6-(8-fluoro-3,4-dihydro-1H-[1]benzofuro[3,2-c]pyridin-2-yl)-N,N-dimethyl-1,3-benzothiazol-2-amine);5-(8-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-N-propan-2-yl-1,3-benzothiazol-2-amine;4-[5-(8-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-2-pyridinyl]morpholine;4-[5-(12-fluoro-8-methyl-4,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),10,12-tetraen-4-yl)-1,3-benzothiazol-2-yl]morpholine;4-[5-(9-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-1,3-benzothiazol-2-yl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-3-pyridinyl]morpholine
Bis(6-(8-fluoro-3,4-dihydro-1H-[1]benzofuro[3,2-c]pyridin-2-yl)-N,N-dimethyl-1,3-benzothiazol-2-amine);5-(8-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-N-propan-2-yl-1,3-benzothiazol-2-amine;4-[5-(8-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-2-pyridinyl]morpholine;4-[5-(12-fluoro-8-methyl-4,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),10,12-tetraen-4-yl)-1,3-benzothiazol-2-yl]morpholine;4-[5-(9-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-1,3-benzothiazol-2-yl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-3-pyridinyl]morpholine (PubChem CID 158767357) has the molecular formula C147H146F7N27O6S5 and a molecular weight of 2680.29 g/mol. Its IUPAC name is bis(6-(8-fluoro-3,4-dihydro-1H-[1]benzofuro[3,2-c]pyridin-2-yl)-N,N-dimethyl-1,3-benzothiazol-2-amine);5-(8-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-N-propan-2-yl-1,3-benzothiazol-2-amine;4-[5-(8-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-2-pyridinyl]morpholine;4-[5-(12-fluoro-8-methyl-4,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),10,12-tetraen-4-yl)-1,3-benzothiazol-2-yl]morpholine;4-[5-(9-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-1,3-benzothiazol-2-yl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-3-pyridinyl]morpholine.
Molecular Properties
| Compound Name | Bis(6-(8-fluoro-3,4-dihydro-1H-[1]benzofuro[3,2-c]pyridin-2-yl)-N,N-dimethyl-1,3-benzothiazol-2-amine);5-(8-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-N-propan-2-yl-1,3-benzothiazol-2-amine;4-[5-(8-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-2-pyridinyl]morpholine;4-[5-(12-fluoro-8-methyl-4,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),10,12-tetraen-4-yl)-1,3-benzothiazol-2-yl]morpholine;4-[5-(9-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-1,3-benzothiazol-2-yl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-3-pyridinyl]morpholine |
|---|---|
| PubChem CID | 158767357 |
| Molecular Formula | C147H146F7N27O6S5 |
| Molecular Weight | 2680.29 g/mol |
| Exact Mass | 2678.04 |
| IUPAC Name | bis(6-(8-fluoro-3,4-dihydro-1H-[1]benzofuro[3,2-c]pyridin-2-yl)-N,N-dimethyl-1,3-benzothiazol-2-amine);5-(8-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-N-propan-2-yl-1,3-benzothiazol-2-amine;4-[5-(8-fluoro-5-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl)-2-pyridinyl]morpholine;4-[5-(12-fluoro-8-methyl-4,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),10,12-tetraen-4-yl)-1,3-benzothiazol-2-yl]morpholine;4-[5-(9-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-1,3-benzothiazol-2-yl]morpholine;4-[6-(8-fluoro-1,3,4,5-tetrahydropyrido[4,3-b]indol-2-yl)-3-pyridinyl]morpholine |
| SMILES | CC(C)Nc1nc2cc(N3CCc4c(c5cc(F)ccc5n4C)C3)ccc2s1.CN(C)c1nc2ccc(N3CCc4oc5ccc(F)cc5c4C3)cc2s1.CN(C)c1nc2ccc(N3CCc4oc5ccc(F)cc5c4C3)cc2s1.Cn1c2c(c3cc(F)ccc31)CN(c1ccc(N3CCOCC3)nc1)CC2.Cn1c2c(c3cc(F)cnc31)CN(c1ccc3sc(N4CCOCC4)nc3c1)CC2.Fc1ccc2[nH]c3c(c2c1)CN(c1ccc(N2CCOCC2)cn1)CC3.Fc1cccc2[nH]c3c(c12)CN(c1ccc2sc(N4CCOCC4)nc2c1)CC3 |
| InChI | InChI=1S/C22H22FN5OS.C22H21FN4OS.C22H23FN4S.C21H23FN4O.C20H21FN4O.2C20H18FN3OS/c1-26-19-4-5-28(13-17(19)16-10-14(23)12-24-21(16)26)15-2-3-20-18(11-15)25-22(30-20)27-6-8-29-9-7-27;23-16-2-1-3-18-21(16)15-13-27(7-6-17(15)24-18)14-4-5-20-19(12-14)25-22(29-20)26-8-10-28-11-9-26;1-13(2)24-22-25-18-11-15(5-7-21(18)28-22)27-9-8-20-17(12-27)16-10-14(23)4-6-19(16)26(20)3;1-24-19-4-2-15(22)12-17(19)18-14-26(7-6-20(18)24)16-3-5-21(23-13-16)25-8-10-27-11-9-25;21-14-1-3-18-16(11-14)17-13-25(6-5-19(17)23-18)20-4-2-15(12-22-20)24-7-9-26-10-8-24;2*1-23(2)20-22-16-5-4-13(10-19(16)26-20)24-8-7-18-15(11-24)14-9-12(21)3-6-17(14)25-18/h2-3,10-12H,4-9,13H2,1H3;1-5,12,24H,6-11,13H2;4-7,10-11,13H,8-9,12H2,1-3H3,(H,24,25);2-5,12-13H,6-11,14H2,1H3;1-4,11-12,23H,5-10,13H2;2*3-6,9-10H,7-8,11H2,1-2H3 |
| InChIKey | IPKTUOZIBICQQO-UHFFFAOYSA-N |
| XLogP | 29.18 |
| TPSA | 266.84 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 36 |
| Rotatable Bonds | 15 |
| Heavy Atoms | 192 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2680.29 |
| LogP ≤ 5 | 29.18 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 36 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'indol_3yl_alk(461)', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158767357 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.